The JAK-STAT3 pathway is involved in cancer cell proliferation and survival (J et al., 2016), and recent studies have identified it as a novel target for cancer therapy (Gharibi et al., 2020; Zou et al., 2020). The gene discussed is STAT3; the disease is cancer.